Acewave P Tab
Cresha Lifesciences - Tablet - 10 S
₹55
Prescription required
Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Medicines with the same active ingredient and strength as Telmifree 40MG Tab.
You are viewing
Telmifree 40MG Tab
tablet - 40 mg - 10 S
₹57
₹5.70 per tablet
Macleods Pharmaceuticals Pvt Ltd · tablet - 40 mg - 15 S · Rx
₹51
₹3.41 per tablet
Telmisartan 40 mg
Treatment of hypertension (high blood pressure); reduction of cardiovascular risk (heart attack, stroke) in high-risk patients when appropriate.
Telmisartan is an angiotensin II receptor blocker (ARB). It blocks AT1 receptors, preventing angiotensin II–mediated vasoconstriction and aldosterone release, thereby lowering blood pressure and reducing cardiovascular strain.
Take by mouth as prescribed, usually once daily, with or without food. Take at the same time each day; do not stop abruptly without medical advice. Dose adjustments may be needed in kidney/liver problems or if used with diuretics.
Common side effects of Telmifree 40MG Tab may include:
Cresha Lifesciences - Tablet - 10 S
Prescription required
Cresha Lifesciences - Tablet - 10 S
Prescription required
Cresha Lifesciences - 170 ml
Prescription required
Cresha Lifesciences - Tablet - 100 mg - 10 S
Prescription required
Cresha Lifesciences - Tablet - 50 mg - 10 S
Cresha Lifesciences - Tablet - 10 S
Cresha Lifesciences - Injection - 2 ml
Cresha Lifesciences - Tablet - 10 S
A substitute contains the same active ingredient (salt), in the same strength, as Telmifree 40MG Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
Not recommended in pregnancy (especially 2nd/3rd trimester) due to risk of fetal harm; avoid in breastfeeding unless advised. Use caution in kidney disease, renal artery stenosis, dehydration/low salt (may cause marked BP fall), and liver impairment. Monitor blood pressure, kidney function (creatinine) and serum potassium, especially after starting or dose changes. Do not use with aliskiren in diabetes; avoid dual blockade with ACE inhibitors/other ARBs unless specifically advised.